Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 6 papers. Top paper: “Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial”.
L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more
Fang Bai, Jingxi Zhang, D. Ye, J. Liu, Zhongneng Xu +7 more
H. Zhu, C. Yang, H. Yang, L. Liu, Song Ma +9 more
A.S. Merseburger, D. Cella, S. Chowdhury, E. Basch, B. Miladinovic +16 more
Z. Li, Cathleen Duan, L. Zhang, Zhuli Cheng, Kaixiang Guan +32 more
D. Ye, Hanxu Guo, Yuchong Yang, Bing Xue, Xiao Zhang +15 more